Atria Investments’s Apyx Medical APYX Stock Holding History

Atria Investments’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$30K	–	951
2018 Q1	$30K	Hold	10,000	–	–	﹤0.01%	868
2017 Q4	$26K	Hold	10,000	–	–	﹤0.01%	814
2017 Q3	$34K	Hold	10,000	–	–	﹤0.01%	787
2017 Q2	$25K	Hold	10,000	–	–	﹤0.01%	749
2017 Q1	$27K	Hold	10,000	–	–	﹤0.01%	675
2016 Q4	$36K	Buy	+10,000	New	+$44.6K	﹤0.01%	627

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Atria Investments's APYX Position: Q2 2018 in Review

Atria Investments sold out of Apyx Medical (APYX) in Q2 2018, closing a stake of 10,000 shares — an estimated $30K sold.

Atria Investments first reported a position in APYX in Q4 2016 and held it in 6 quarters. The position peaked at $36K in Q4 2016. 47 funds tracked by Wall St. Rank hold APYX as of Q2 2018.

Atria Investments reported no remaining Apyx Medical position as of Q2 2018 after selling out during the quarter.
Atria Investments sold 10,000 Apyx Medical shares in Q2 2018, an estimated $30K.
Atria Investments first reported a position in Apyx Medical in Q4 2016 and held it in 6 quarters.
Atria Investments's Apyx Medical position peaked at $36K in Q4 2016.
47 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2018.

Based on Atria Investments's 13F filing for Q2 2018, filed 13 Jul 2018.